Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma

BMC Cancer201717:551

https://doi.org/10.1186/s12885-017-3539-3

Received: 6 March 2017

Accepted: 10 August 2017

Published: 17 August 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
6 Mar 2017 Submitted Original manuscript
15 Apr 2017 Reviewed Reviewer Report - Xiaotao Jiang
16 Apr 2017 Reviewed Reviewer Report - Zong Sheng Guo
16 Apr 2017 Reviewed Reviewer Report - Yukai He
14 Jun 2017 Author responded Author comments - Dennis Harrer
Resubmission - Version 2
14 Jun 2017 Submitted Manuscript version 2
17 Jul 2017 Author responded Author comments - Dennis Harrer
Resubmission - Version 3
17 Jul 2017 Submitted Manuscript version 3
27 Jul 2017 Author responded Author comments - Dennis Harrer
Resubmission - Version 4
27 Jul 2017 Submitted Manuscript version 4
3 Aug 2017 Author responded Author comments - Dennis Harrer
Resubmission - Version 5
3 Aug 2017 Submitted Manuscript version 5
Publishing
10 Aug 2017 Editorially accepted
17 Aug 2017 Article published 10.1186/s12885-017-3539-3

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Dermatology, Universitätsklinikum Erlangen
(2)
Department of Dermatology, Faculty of Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
(3)
Department of Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg Erlangen-Nürnberg
(4)
Laboratory for Immunotherapy, RIKEN Center for Integrative Medical Sciences (IMS)

Advertisement